Skip to main content

News Archive

News Archive - School of Medicine

Kidneys Aren’t Harmed When Significantly Lowering Blood Pressure

October 22, 2018

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself. Instead, any negative changes to clinical results are more likely due to decreased blood flow.

UC San Diego Epidemiologist Named to TIME’s 50 Most Influential People in Health Care

October 18, 2018

Steffanie Strathdee, PhD, associate dean of global health sciences at University of California San Diego School of Medicine, was named today one of TIME magazine’s 50 Most Influential People in Health Care for 2018, which identifies people who “have changed the state of health care in America this year, and bear watching for what they do next.”

Video Monitoring of Tuberculosis Treatment Effective in Urban and Rural Areas

October 16, 2018

Researchers from University of California San Diego School of Medicine, with statewide collaborators, report that patients who recorded videos of themselves taking tuberculosis (TB) medications better adhered to treatment than patients who were observed in-person.

UC San Diego Health’s Lucila Ohno-Machado Elected to National Academy of Medicine

October 15, 2018

Lucila Ohno-Machado, MD, PhD, chair of the Department of Biomedical Informatics at UC San Diego Health, professor of medicine and associate dean for informatics and technology at the School of Medicine, and a founding faculty member of UC San Diego Halicioğlu Data Science Institute, has been elected to the National Academy of Medicine (NAM).

Is the Next Big Step in Cancer Therapy Personalized Vaccines?

October 12, 2018

Tamara Strauss has been living with high-grade, stage IV pancreatic neuroendocrine cancer for more than three years. Current treatments, although effective for her, are highly toxic. Tamara enrolled in a first-of-its-kind, pilot study at Moores Cancer Center at UC San Diego Health to test a personalized vaccine using her unique cancer mutations to boost an anti-tumor immune response.

Lung Cancer Deaths are 28 Percent Lower in California

October 10, 2018

Early adoption of tobacco control efforts in California led to fewer people ever smoking, reduced the amount used by those who do smoke and helped smokers quit at a younger age — when their risk of developing lung cancer is lowest. As a result, lung cancer deaths are 28 percent lower in California compared to the rest of the country and the gap is widening each year by almost a percentage point.

UC San Diego Health Expands Primary Care Options

October 8, 2018

On Monday, October 15, UC San Diego Health will open a new comprehensive health center located at 16950 Via Tazon in Rancho Bernardo. Described as a “clinic of the future,” the new 57,000 square foot facility will offer patients increased access to a team of top doctors and nurses, and an array of convenient services, such as urgent care and advanced imaging, including a pharmacy and optical boutique.

Participants in Dementia Prevention Research Motivated by Altruism

October 5, 2018

Researchers at University of California San Diego School of Medicine, with collaborators across the country, report that people who participate in dementia prevention trials are primarily motivated by altruism and pleased to help.

A New and Dire Diagnosis: Human Trafficking

October 4, 2018

Starting in the fall of 2018, UC San Diego Health will be the first health system in San Diego County to implement a policy ensuring that all mandatory reporters are responsible for reporting cases of suspected human trafficking. This policy will be a coordinated effort of administrative and professional staff at all points of entry into the health system.

Study Finds Human Milk Components in Amniotic Fluid

October 2, 2018

Human milk oligosaccharides (HMOs) are complex carbohydrates that are highly abundant and unique to human milk. Accumulating evidence indicates that exposure to HMOs in the postnatal period has both immediate and long-term benefits to infant health and development. Researchers at University of California San Diego School of Medicine report for the first time that HMOs are also present in amniotic fluid.
Category navigation with Social links